Company Filing History:
Years Active: 2020-2024
Title: Carrie Brownstein: Innovator in Cancer Treatment
Introduction
Carrie Brownstein is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment, holding a total of 3 patents. Her work focuses on innovative methods to combat various forms of cancer, particularly B-cell cancers.
Latest Patents
One of her latest patents involves a combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer. This invention provides methods for treating, reducing the severity, or inhibiting the growth of cancers such as Hodgkin's lymphoma or acute lymphoblastic leukemia. The methods include administering a therapeutically effective amount of an antibody that specifically binds to the programmed death 1 (PD-1) receptor, in combination with a bispecific antibody that binds to CD20 and CD3.
Another notable patent addresses a dosing strategy that mitigates cytokine release syndrome for therapeutic antibodies. This patent discloses administration regimens for therapeutic proteins, such as T cell-activating bispecific antibodies, that help reduce cytokine release syndrome and infusion-related reactions. The methods involve initial fractional dosing, with optional administration of additional agents like steroids or cytokine antagonists, which are discontinued with maximal weekly dosing throughout the regimen.
Career Highlights
Carrie Brownstein is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research and innovations in cancer therapies. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various cancers.
Collaborations
Some of her notable coworkers include Israel Lowy and Bindu Varghese, who collaborate with her on various projects aimed at enhancing cancer treatment methodologies.
Conclusion
Carrie Brownstein's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work not only showcases her expertise but also reflects the ongoing efforts to improve therapeutic options for patients facing challenging diagnoses.